Y-Biologics, Inc. (KOSDAQ:338840)
23,950
+1,100 (4.81%)
At close: Mar 6, 2026
Y-Biologics Market Cap
Y-Biologics has a market cap or net worth of 348.34 billion as of March 9, 2026. Its market cap has increased by 215.45% in one year.
Market Cap
348.34B
Enterprise Value
325.21B
Revenue
3.61B
Ranking
n/a
PE Ratio
n/a
Stock Price
23,950.00
Market Cap Chart
Since December 5, 2023, Y-Biologics's market cap has increased from 177.50B to 348.34B, an increase of 96.25%. That is a compound annual growth rate of 34.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 348.34B | 0.22% |
| Dec 30, 2025 | 347.58B | 205.76% |
| Dec 30, 2024 | 113.68B | -50.64% |
| Dec 28, 2023 | 230.30B | 29.75% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| curacle co.,ltd. | 354.71B |
| NIBEC | 338.70B |
| S.Biomedics | 448.34B |
| Bio Solution | 281.61B |
| ABION | 259.94B |
| Genome & Company | 245.30B |
| ISU Abxis | 206.04B |
| IntoCell | 644.01B |